March 14, 2015
3 min read
Save

Pre-hospital treatment delays result in poorer STEMI outcomes for women

SAN DIEGO — Women with STEMI are more likely than men to have delays between symptom onset and treatment, resulting in higher in-hospital mortality, according to results presented at the American College of Cardiology Scientific Sessions.

Perspective from Mary Norine Walsh, MD, FACC

Researchers reported data from a study of 7,457 patients with STEMI (2,282 women) who were enrolled in the ISACS-TC registry from 2010 to 2014.

The average delay between symptoms and calling emergency medical services was 60 minutes among women compared with 45 minutes among men. Women were also more likely to have a home-to-hospital delay of 60 minutes or longer (70.3% vs. 29.7%).

Receipt of care within 12 hours of symptom onset was reported in 76% of women compared with 80.4% of men (P < .001).

Reperfusion therapy occurred less common among women (69.5% vs. 73.5%; P = .003). Factors associated with lower rates of reperfusion therapy included a delay of 12 hours or longer from symptom onset to treatment (adjusted OR = 5.37; 95% CI, 4.58-6.31), prior HF (OR = 2.77; 95% CI, 1.99-3.87) and Killip class 2 (OR = 1.53; 95% CI, 1.27-1.86).

Overall, the in-hospital mortality rate was 11.8% for women vs. 6.3% for men. After adjustment for confounders, in-hospital mortality was significantly more common among women (OR = 1.34; 95% CI, 1.01-1.77). However, researchers noted that multivariable analyses adjusting for home-to-hospital delay of 60 minutes or less eliminated the difference in in-hospital mortality rates between sexes (OR = 0.9; 95% CI, 0.31-2.56 for women vs. men).

Raffaele Bugiardini, MD, FACC, FAHA, FESC

Raffaele Bugiardini

In other results, door-to-needle and door-to-balloon times were similar between women and men. During a press briefing held prior to the ACC Scientific Sessions, Raffaele Bugiardini, MD, FACC, FAHA, FESC, professor of clinical cardiology at the University of Bologna, Italy, said these results suggest that the differences between women and men do not persist once patients have entered the hospital.

"Our analyses indicate that sex differences in outcomes persist [among STEMI patients] because the women have worse in-hospital mortality," Bugiardini said. "Fewer women receive timely reperfusion therapy, which appears to be driven by longer pre-hospital delays. Heart disease is also a women's disease, and it is important to approach this issue through education initiatives aimed at patients ... but also at the physician level, to promote early access to the health system." - by Adam Taliercio and Erik Swain

Reference:

Bugiardini R, et al. Abstract 1125M-17. Presented at: American College of Cardiology Scientific Sessions; March 14-16, 2015; San Diego.

Disclosure: One researcher reports serving on a speaker's bureau for KRKA, a pharmaceutical company in Macedonia.